Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
detroit blog main
detroit top stories
8
×
life sciences
national blog main
national top stories
new york blog main
8
×
new york top stories
8
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
boulder/denver blog main
boulder/denver top stories
cancer
indiana blog main
indiana top stories
national
clinical trials
eli lilly
cancer immunotherapy
fda
startups
deals
merck
abbvie
alzheimer's disease
bristol-myers squibb
celgene
drugs
What
companies
8
×
bio
roundup
drug
life
new
science
week
approval
big
biotechs
fda
ipo
latest
nash
news
price
sciences
therapeutics
therapies
year
admits
ago
alzheimer’s
approved
arena’s
arguments
biogen’s
biopharmaceutical
black
bounty
cig
class
classes
club
combinator
comeback
commercialized
competitors
continue
Language
unset
Current search:
companies
×
" new york blog main "
×
" new york top stories "
×
" detroit top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M